Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$809,145
+$6,750 QoQ
Shares Held
5,163
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#692
of 1,603 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kennebec Savings Bank holds $7,180,098 across 9 Drug Manufacturers - General names. NVS ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,247 | $2,326,915 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,803 | $2,159,185 | |
| 3 | JNJ |
Johnson & Johnson
|
5,867 | $1,490,041 | |
| 4 | NVS |
Novartis AG
This page
|
5,163 | $809,145 | |
| 5 | LLY |
ELI LILLY & Co
|
193 | $231,490 | |
| 6 | PFE |
Pfizer Inc
|
2,600 | $62,608 | |
| 7 | AMGN |
Amgen Inc
|
126 | $45,627 | |
| 8 | NVO |
Novo Nordisk A S
|
892 | $42,762 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $809,145 | 5,163 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $802,395 | 5,253 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $732,916 | 5,316 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $653,767 | 5,098 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $658,899 | 5,445 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $634,767 | 5,694 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $513,991 | 5,282 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $619,037 | 5,382 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||